SIRT1 and age: This study therefore not only identifies novel mechanisms of 1,25(OH)2D deficiency in accelerating age-related knee OA development, but may also provide experimental and theoretical evidence for potential utilization of 1,25(OH)2D3 or downstream targets, including Sirt1 activators to prevent age-related knee OA.